Document is current
Any future updates will be listed below
-
Authors
Segel, Reeval https://orcid.org/0000-0001-5807-9223
Aran, Adi
Gulsuner, Suleyman
Nakamura, Hiroki
Rosen, Tzvia
Walsh, Tom
Denda, Hiroto
Zeligson, Sharon
Eto, Katsuki
Beeri, Rachel
Okai, Haruka
King, Mary-Claire
Levy-Lahad, Ephrat
Funato, Kouichi
Renbaum, Paul
-
Funding
Funding for this research was provided by:
National Institute of Health (MH083989)
JSPS KAKENHI
Hassenfeld family to Shaare Zedek Medical Center
- License Information
-
More Information
Article History
Received: 5 March 2020
Accepted: 5 May 2020
First Online: 27 May 2020
Compliance with ethical standards
:
: Aran Adi reports receiving personal fees and options for advisory roles at BOL Pharma, no relevance for the submitted paper. All other authors declare that they have no conflict of interest.
: The study was approved by the Institutional Review Board of Shaare Zedek Medical Center and the Israel National Ethics Committee for Genetic Studies (protocol 20/10) and the University of Washington Institutional Review Board.
: Blood samples were obtained after written informed consent to participate.
